Immunodiagnostic Systems Hldgs PLC Launch of two new automated assays (4465J)
March 29 2018 - 8:32AM
UK Regulatory
TIDMIDH
RNS Number : 4465J
Immunodiagnostic Systems Hldgs PLC
29 March 2018
Immunodiagnostic Systems Holdings plc.
29 March 2018
Launch of two new automated assays
Launch of IDS SHBG assay - new addition to the IDS Fertility
portfolio
Launch of the IDS ACE assay - first biochemistry test for the
IDS Automated System
Immunodiagnostic Systems Holdings plc (IDS), a specialty
solution provider to the clinical laboratory diagnostic market,
today launched the IDS SHBG and the IDS ACE assays in the European
market for use with the IDS Automated System.
The IDS SHBG assay measures the levels of sex hormone binding
protein in blood samples. Measurement of SHBG concentrations can be
used to assist in the diagnosis of androgen disorders such as
primary and secondary hypogonadism, delayed or precocious puberty,
impotence in males, polycystic ovaries in females, and
adrenogenital syndromes. This assay extends the IDS Fertility
portfolio, and complements the recently launched Total
Testosterone, Free Testosterone and 17-OH Progesterone assays.
These assays allow laboratories to improve their workflow with the
IDS automated platform.
The commercialisation of the IDS ACE assay marks the first
biochemistry test on the IDS Automated System.
Angiotensin-Converting Enzyme (ACE) blood tests can be used for
monitoring the therapeutic treatment of diagnosed Sarcoidosis.
Sarcoidosis is a multisystem inflammatory disease of unknown cause
that predominantly affects the lungs and intrathoracic lymph nodes.
Apart from this inflammatory disease, ACE levels may also be
altered in conditions such as tuberculosis, multiple sclerosis and
cystic fibrosis.
The Global market size for SHBG and ACE testing is estimated to
be around $10-15 million each worldwide.
For further information:
Immunodiagnostic Systems Holdings plc Tel: +44 (0) 191 519 0660
Jaap Stuut, Chief Executive Officer
Paul Martin, Group Finance Director
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
PRLLLFFFVTIAFIT
(END) Dow Jones Newswires
March 29, 2018 08:32 ET (12:32 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Apr 2024 to May 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From May 2023 to May 2024